Because elevated serum IL-6 levels are associated with the aggressiveness of prostate cancer and may represent a predictive marker of biochemical recurrence after prostatectomy, preoperative evaluation of changes in serum IL-6 levels may be valuable for not only surgical stress detection but also prognosis prediction21. This evidence concerns the gene IL6 and prostate carcinoma.